Zobrazeno 1 - 10
of 1 909
pro vyhledávání: ''
Autor:
Hirohisa Endo, Hiroki Nishiyama, Kikuo Isoda, Hiroyuki Daida, Tomotaka Dohi, Norihito Takahashi, Yoshiteru Kato, Yuichi Chikata, Shinichiro Doi, Tatsuya Fukase, Katsumi Miyauchi, Iwao Okai, Hiroshi Iwata, Shinya Okazaki, Tohru Minamino
Publikováno v:
Atherosclerosis. 333:9-15
Little is known about the long-term impact of apolipoprotein E (apoE) on residual cardiovascular risk in patients with chronic coronary syndrome (CCS) receiving statin treatment.A total of 1109 consecutive patients (mean age, 67 ± 10 years; 83% men)
Autor:
Norman E. Lepor, Thomas S. Hatsukami, Jie Sun, Niranjan Balu, Chun Yuan, Americo A. Simonini, Daniel S. Hippe, Ilan Kedan, Laurn Contreras, Daniel Isquith, Xue-Qiao Zhao, Gador Canton
Publikováno v:
Atherosclerosis. 327:31-38
Background and aims Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors reduce cardiovascular events, but their effects on atherosclerotic plaque remain elusive. Using serial magnetic resonance imaging (MRI), we studied changes in caroti
Publikováno v:
Atherosclerosis. 324:141-147
Background and aims Sex differences in cardiovascular prevention have been reported, yet the role of sex with regard to different modifiable risk factors such as low-density lipoprotein cholesterol (LDL-C), systolic blood pressure (BP), and glycated
Autor:
Shoichiro Izawa, Yuichiro Yano, Mitsuhide Naruse, Yoshiro Chiba, Tatsuya Kai, Kouichi Tamura, Norio Wada, Nobuhito Hirawa, Shintaro Okamura, Kenji Oki, Akiyo Tanabe, Takamasa Ichijo, Isao Kurihara, Nobuya Inagaki, Mika Tsuiki, Masanobu Yamada, Takuyuki Katabami, Koichi Yamamoto, Hiroki Kobayashi, Tatsuya Haze
Publikováno v:
Atherosclerosis. 324:84-90
Background and aims We used a dataset from a Japanese nationwide registry of patients with primary aldosteronism, to determine which of the parameters of hyperaldosteronism and blood pressure before or after treatments for primary aldosteronism (i.e.
Autor:
John R Nelson, Suvasini Lakshmanan, Chandana Shekar, Deepak L. Bhatt, Sion K. Roy, April Kinninger, Sajad Hamal, A. Cai, Divya Birudaraju, Christopher Dailing, Matthew J. Budoff, S. Dahal, Ferdinand Flores, Lavanya Cherukuri, A. Onuegbu
Publikováno v:
Atherosclerosis. 305:34-41
Background and aims Dyslipidemia with elevated triglycerides (TGL) and low high-density lipoprotein cholesterol (HDL-C) predicts residual cardiovascular risk, despite goal LDL-C levels and optimal statin therapy. Coronary plaque characterization by C
Autor:
Ding Ding, Chu-wen Ling, Yu-ming Chen, Luo-Shi-Yuan Zuo, Feng Xiong, Yue-Bin Ke, Qing-Wei Zhong
Publikováno v:
Atherosclerosis. 298:7-13
The relationship of polyunsaturated fatty acids (PUFAs) with cardiovascular risk is still controversial. We aimed to determine whether erythrocyte n-3 and n-6 PUFAs are related to the risk of carotid atherosclerosis.From 2008 to 2019, baseline erythr
Publikováno v:
Atherosclerosis. 299:1-8
Background and aims Statin associated muscle symptoms are common and affect adherence to statin treatment. The objective of this study was to assess whether patients with statin-associated myalgia can be successfully treated with Coenzyme Q10 (CoQ10)
Autor:
Xia Meng, Hao Li, Jinxi Lin, Yilong Wang, Yongjun Wang, Anxin Wang, Nan Zhang, Guojuan Chen, Liye Dai, Yingting Zuo
Publikováno v:
Atherosclerosis. 297:74-80
Low-density lipoprotein (LDL) and oxidized low-density lipoprotein (oxLDL) levels are thought to be related to recurrent stroke. However, the joint association of circulating LDL and oxLDL levels with the outcomes of acute minor ischemic stroke and t
Autor:
Parveen K. Garg, Steven Shea, Matthew A. Allison, James H. Stein, Laurent Yvan-Chavret, Robyn L. McClelland, Neal W. Jorgensen, Alan R. Tall
Publikováno v:
Atherosclerosis
Background and aims We aimed to assess the relationship of HDL (high-density lipoprotein)-mediated cholesterol mass efflux capacity (CMEC) with risk of incident peripheral artery disease (PAD). Methods CMEC was measured in 1458 Multi-Ethnic Study of
Autor:
Vito Di Marco, Vincenza Calvaruso, Salvatore Petta, Mariarosaria Saturnino, Riccardo Nevola, Pia Clara Pafundi, Ferdinando Carlo Sasso, Carmine Coppola, Graziano Troina, Aldo Marrone, Francesca Rini, Laura Staiano, Anna Ludovica Fracanzani, Barbara Guerrera, Mauro Giordano, Luigi Elio Adinolfi, Vincenzo Narciso, Rosa Lombardi, Luca Rinaldi, Antonio Craxì, Antonio Solano
Publikováno v:
Atherosclerosis. 296:40-47
Background and aims: HCV is associated with an increased risk of cardiovascular events (CV). Whether HCV clearance by direct-acting antivirals (DAA) reduces incident CV disease is poorly understood. We investigate whether HCV eradication reduces CV e